000963:SHE
Huadong Medicine Co., Ltd.
CNÂ¥26,30
arrow_downward
-0,04%(-0,010) 1D
15 Okt., 15:04:21 GMT+8 · CNY
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 000963...
Open
CNÂ¥26,02
High
CNÂ¥26,52
Low
CNÂ¥25,95
Mkt. cap
46,61Â mjd
Avg. vol.
13,39Â m
Volume
12,14Â m
Dividend
3,54%
Quarterly dividend
CNÂ¥0,23
Ex-dividend date
18 Sep. 2026
P/E ratio
13,30
52-wk high
CNÂ¥43,78
52-wk low
CNÂ¥25,63
EPS
CNÂ¥1,98
Shares outstanding
1,75Â mjd
No. of employees
19Â k
Open
CNÂ¥26,02
High
CNÂ¥26,52
Low
CNÂ¥25,95
Mkt. cap
46,61Â mjd
Avg. vol.
13,39Â m
Volume
12,14Â m
Dividend
3,54%
Quarterly dividend
CNÂ¥0,23
Ex-dividend date
18 Sep. 2026
P/E ratio
13,30
52-wk high
CNÂ¥43,78
52-wk low
CNÂ¥25,63
EPS
CNÂ¥1,98
Shares outstanding
1,75Â mjd
No. of employees
19Â k
News stories
From web sources and news partners
Stocktwits
·
45 minute gelede
Why Are Nasdaq Futures Sinking Premarket? CRWV, MU, TSM, SKHY, IBRX, RKLB, TSLA Stocks In Focus
Simply Wall Street
·
4 minute gelede
BioNTech (BNTX), What Is Behind The Latest Attention?
Yahoo Finance
·
20 minute gelede
A Staggering 84% of S&P 500 Stocks Are Now in Correction Territory, and History Says This Foreshadows Disaster for Wall Street
Reuters
·
1 uur gelede
Nasdaq futures dive 1% as AI rout deepens on debt concerns
Profile
HD Medicine, or Huadong Medicine Co., Ltd., is a Hangzhou-based pharmaceutical company registered on the Shenzhen Stock Exchange since December 1999. It has a listed share capital of 380,000,000 RMB and a market capitalization of 5.1981 billion RMB as of June 2026. It is the largest pharmaceutical company in Zhejiang and the leading immunosuppressant manufacturer in China.
In June 2025, the company received approval to commence clinical trials for Roflumilast Foam, targeting dermatological conditions. Wikipedia
About Huadong Medicine Co., Ltd.
CEO-
Employees19,1Â k
Founded31 Mrt. 1993
Headquarters-
SectorHealth care provider
Websiteeastchinapharm.com